Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | fructose-1,6-bisphosphate aldolase | 0.0263 | 0.1097 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0069 | 0.0186 | 0.5 |
Loa Loa (eye worm) | phosphatidylinositol-specific phospholipase C | 0.0048 | 0.0088 | 0.0018 |
Brugia malayi | Thioredoxin reductase | 0.0069 | 0.0186 | 0.0186 |
Loa Loa (eye worm) | ryanodine receptor | 0.0317 | 0.1346 | 0.1846 |
Loa Loa (eye worm) | hypothetical protein | 0.1329 | 0.608 | 0.8724 |
Leishmania major | inositol-1,4,5-trisphosphate (IP3) 5-phosphatase, putative | 0.0089 | 0.0282 | 0.0704 |
Trypanosoma cruzi | inositol-1,4,5-trisphosphate (IP3) 5-phosphatase, putative | 0.0089 | 0.0282 | 0.0441 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.0263 | 0.1097 | 0.2291 |
Echinococcus granulosus | fructose 16 bisphosphate aldolase | 0.0263 | 0.1097 | 0.2529 |
Echinococcus multilocularis | fructose 1,6 bisphosphate aldolase | 0.0263 | 0.1097 | 0.2529 |
Brugia malayi | MIR domain containing protein | 0.0184 | 0.0725 | 0.0725 |
Trypanosoma brucei | fructose-bisphosphate aldolase, glycosomal, putative | 0.0263 | 0.1097 | 0.2291 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.0282 | 0.03 |
Trypanosoma brucei | inositol-1,4,5-trisphosphate (IP3) 5-phosphatase, putative | 0.0093 | 0.0302 | 0.0485 |
Loa Loa (eye worm) | Plcb4 protein | 0.0105 | 0.0356 | 0.0407 |
Leishmania major | hypothetical protein, conserved | 0.0672 | 0.3009 | 1 |
Schistosoma mansoni | guanyl-nucleotide exchange factor | 0.0099 | 0.0327 | 0.017 |
Schistosoma mansoni | fructose 16-bisphosphate aldolase | 0.0263 | 0.1097 | 0.1103 |
Toxoplasma gondii | fructose-1,6-bisphosphate aldolase | 0.0263 | 0.1097 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1496 | 0.6857 | 0.9853 |
Onchocerca volvulus | 0.0184 | 0.0725 | 1 | |
Loa Loa (eye worm) | fructose-bisphosphate aldolase 2 | 0.0263 | 0.1097 | 0.1483 |
Brugia malayi | Phosphatidylinositol-specific phospholipase C, X domain containing protein | 0.0045 | 0.0076 | 0.0076 |
Schistosoma mansoni | stromal cell-derived factor 2 precursor-like protein | 0.0184 | 0.0725 | 0.0653 |
Loa Loa (eye worm) | variant SH3 domain-containing protein | 0.0051 | 0.0102 | 0.0039 |
Brugia malayi | Phosphatidylinositol-specific phospholipase C, X domain containing protein | 0.0048 | 0.0088 | 0.0088 |
Schistosoma mansoni | ryanodine receptor 1 skeletal muscle | 0.0317 | 0.1346 | 0.1406 |
Trypanosoma cruzi | inositol 1,4,5-trisphosphate receptor, putative | 0.0989 | 0.4489 | 1 |
Leishmania major | trypanothione reductase | 0.0069 | 0.0186 | 0.0376 |
Echinococcus multilocularis | 1 phosphatidylinositol 4,5 bisphosphate | 0.0108 | 0.0368 | 0.0506 |
Plasmodium vivax | glutathione reductase, putative | 0.0069 | 0.0186 | 0.1081 |
Loa Loa (eye worm) | fructose-bisphosphate aldolase 1 | 0.0263 | 0.1097 | 0.1483 |
Echinococcus multilocularis | ryanodine receptor 44f | 0.0839 | 0.3786 | 1 |
Echinococcus granulosus | 1-Phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-4 | 0.0108 | 0.0368 | 0.0506 |
Loa Loa (eye worm) | MIR domain-containing protein | 0.0184 | 0.0725 | 0.0943 |
Echinococcus granulosus | cytohesin 1 | 0.0099 | 0.0327 | 0.0391 |
Echinococcus multilocularis | cytohesin 1 | 0.0099 | 0.0327 | 0.0391 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.0282 | 0.03 |
Plasmodium falciparum | fructose-bisphosphate aldolase | 0.0263 | 0.1097 | 1 |
Brugia malayi | Cytohesin 3 | 0.0099 | 0.0327 | 0.0327 |
Echinococcus multilocularis | fructose 1,6 bisphosphate aldolase | 0.0263 | 0.1097 | 0.2529 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.0263 | 0.1097 | 0.2291 |
Brugia malayi | Variant SH3 domain containing protein | 0.0051 | 0.0102 | 0.0102 |
Echinococcus granulosus | fructose 16 bisphosphate aldolase | 0.0263 | 0.1097 | 0.2529 |
Trypanosoma cruzi | inositol-1,4,5-trisphosphate (IP3) 5-phosphatase, putative | 0.0089 | 0.0282 | 0.0441 |
Trichomonas vaginalis | mannosyltransferase 1, putative | 0.0184 | 0.0725 | 0.5 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0069 | 0.0186 | 0.016 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0069 | 0.0186 | 0.1081 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.1834 | 0.8438 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0069 | 0.0186 | 0.0222 |
Onchocerca volvulus | 0.0144 | 0.0537 | 0.4743 | |
Echinococcus granulosus | ryanodine receptor 44f | 0.0839 | 0.3786 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0839 | 0.3786 | 0.5392 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.0263 | 0.1097 | 0.2291 |
Echinococcus multilocularis | stromal cell derived factor 2 | 0.0184 | 0.0725 | 0.1496 |
Echinococcus granulosus | stromal cell derived factor 2 | 0.0184 | 0.0725 | 0.1496 |
Brugia malayi | glutathione reductase | 0.0069 | 0.0186 | 0.0186 |
Loa Loa (eye worm) | hypothetical protein | 0.1517 | 0.6958 | 1 |
Brugia malayi | Ryanodine Receptor TM 4-6 family protein | 0.1173 | 0.5348 | 0.5348 |
Echinococcus multilocularis | fructose 1,6 bisphosphate aldolase | 0.0263 | 0.1097 | 0.2529 |
Brugia malayi | phospholipase C homolog | 0.0079 | 0.0234 | 0.0234 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.1329 | 0.608 | 0.7142 |
Leishmania major | fructose-1,6-bisphosphate aldolase | 0.0263 | 0.1097 | 0.348 |
Schistosoma mansoni | phospholipase C-like protein 2 plc-L2 | 0.0079 | 0.0234 | 0.0058 |
Brugia malayi | fructose-bisphosphate aldolase 1 | 0.0263 | 0.1097 | 0.1097 |
Leishmania major | phospholipase c-like protein | 0.0048 | 0.0088 | 0.0043 |
Plasmodium falciparum | glutathione reductase | 0.0069 | 0.0186 | 0.1081 |
Schistosoma mansoni | ryanodine receptor related | 0.1173 | 0.5348 | 0.6256 |
Loa Loa (eye worm) | hypothetical protein | 0.0251 | 0.104 | 0.1401 |
Plasmodium falciparum | thioredoxin reductase | 0.0069 | 0.0186 | 0.1081 |
Echinococcus granulosus | fructose 16 bisphosphate aldolase | 0.0263 | 0.1097 | 0.2529 |
Toxoplasma gondii | thioredoxin reductase | 0.0069 | 0.0186 | 0.0969 |
Schistosoma mansoni | phospholipase C beta | 0.0105 | 0.0356 | 0.0206 |
Echinococcus granulosus | ryanodine receptor 44f | 0.0651 | 0.2908 | 0.756 |
Schistosoma mansoni | phospholipase C-like protein 2 plc-L2 | 0.0172 | 0.0672 | 0.0588 |
Brugia malayi | 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta 4 | 0.0105 | 0.0356 | 0.0356 |
Loa Loa (eye worm) | hypothetical protein | 0.0144 | 0.0537 | 0.0671 |
Loa Loa (eye worm) | hypothetical protein | 0.0108 | 0.0368 | 0.0425 |
Plasmodium vivax | fructose 1,6-bisphosphate aldolase, putative | 0.0263 | 0.1097 | 1 |
Schistosoma mansoni | fructose 16-bisphosphate aldolase | 0.0263 | 0.1097 | 0.1103 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.0282 | 0.03 |
Toxoplasma gondii | fructose-bisphosphate aldolase, putative | 0.0263 | 0.1097 | 1 |
Entamoeba histolytica | MIR domain protein | 0.0184 | 0.0725 | 0.5 |
Echinococcus multilocularis | ryanodine receptor 44f | 0.0651 | 0.2908 | 0.756 |
Echinococcus multilocularis | fructose bisphosphate aldolase class I | 0.0263 | 0.1097 | 0.2529 |
Trypanosoma brucei | inositol 1,4,5-trisphosphate receptor | 0.0989 | 0.4489 | 1 |
Brugia malayi | fructose-bisphosphate aldolase 2 | 0.0263 | 0.1097 | 0.1097 |
Trypanosoma brucei | trypanothione reductase | 0.0069 | 0.0186 | 0.0222 |
Echinococcus granulosus | fructose bisphosphate aldolase class I | 0.0263 | 0.1097 | 0.2529 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.0263 | 0.1097 | 0.2291 |
Loa Loa (eye worm) | glutathione reductase | 0.0069 | 0.0186 | 0.016 |
Loa Loa (eye worm) | cytohesin 3 | 0.0099 | 0.0327 | 0.0365 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | = 68 % | Inhibition of TGFbeta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM | ChEMBL. | 18262787 |
Activity (binding) | = 68 % | Inhibition of TGFbeta-induced ALK5 in human HaCaT cells assessed as SBE-luciferase activity at 0.1 uM | ChEMBL. | 18262787 |
Activity (binding) | = 98 % | Inhibition of TGFbeta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM | ChEMBL. | 18262787 |
Activity (binding) | = 98 % | Inhibition of TGFbeta-induced ALK5 in human HaCaT cells assessed as p3TP-luciferase activity at 0.1 uM | ChEMBL. | 18262787 |
Activity (binding) | = 99 % | Inhibition of TGFbeta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM | ChEMBL. | 18262787 |
Activity (binding) | = 99 % | Inhibition of TGFbeta-induced ALK5 in human HaCaT cells assessed as ARE-luciferase activity at 0.1 uM | ChEMBL. | 18262787 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.